Author | Jeffrey Jones, MD | OncLive

Author | Jeffrey Jones, MD

Articles

Dr. Jeffrey Jones on NCCN Recommendations for Relapsed Patients With CLL

April 04, 2016

Video

Jeffrey Jones, MD, MPH, assistant professor of Internal Medicine, Division of Hematology, Department of Internal Medicine, Ohio State University Wexner Medical Center, discusses NCCN recommendations for treatment of relapsed patients with chronic lymphocytic leukemia (CLL).

Dr. Jeffrey Jones on Idelalisib Combinations in CLL

July 22, 2015

Video

Jeffrey Jones, MD, MPH, Assistant Professor of Internal Medicine and section head of the Chronic Lymphocytic Leukemia (CLL) research program at Ohio State University, discusses idelalisib (Zydelig) combinations in CLL.

Dr. Jeffrey Jones on Efficacy of Idelalisib/Ofatumumab Combination in CLL

May 31, 2015

Video

Jeffrey Jones, MD, MPH, Assistant Professor of Internal Medicine and section head of the Chronic Lymphocytic Leukemia (CLL) research program at Ohio State University, discusses the results of a phase III randomized, controlled study evaluating idelalisib (Zydelig) in combination with ofatumumab (Arzerra) compared to ofatumumab alone for previously treated CLL.

x